Form 4: Tenet Healthcare Director Trades THC Stock

Tenet Healthcare Corp. Director Nadja West reported transactions involving common stock and restricted stock units.

Summary

• Director Nadja West of Tenet Healthcare Corp. (THC) engaged in stock transactions on May 22, 2026.
• West acquired 1,333 shares of common stock through the settlement of restricted stock units.
• Additionally, West disposed of 493 shares of common stock for $173.78 per share.
• Following these transactions, West beneficially owns 28,298 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, reflecting routine insider transactions without significant positive or negative implications on its own.

Positives

• Director Nadja West acquired additional shares through restricted stock unit settlement, indicating continued alignment with the company's performance.
• The settlement of restricted stock units suggests that performance targets or vesting conditions were met.

Negatives

• Director Nadja West disposed of 493 shares of common stock, which could be interpreted as a reduction in direct ownership.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions. While individual transactions can provide signals, they should be analyzed within the broader context of the company's financial health and strategic direction.

Stakeholder Impact

• Shareholders: The acquisition of shares via RSU settlement may be viewed positively, while the disposition of shares could be a point of observation, though typical for insider compensation plans.
• Management: The transactions reflect standard compensation and ownership practices for a director.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Stock Transaction, Director, Restricted Stock Units, Beneficial Ownership